Original InvestigationOral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
This project was supported by grant number U19HS021092 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Additional funding was provided by the Duke Clinical Research Institute. Dr. Pokorney has received research grants from Boston Scientific, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, and Gilead; has received consulting and research support from Bristol-Myers Squibb, Pfizer, Medtronic, Boston Scientific, and Janssen Pharmaceuticals; has received research support from the Food and Drug Administration; and has received Speakers Bureau support from Zoll. Dr. Friedman has received salary support from Boston Scientific and Abbott; has received consulting fees from Abbott and AtriCure; has received research support from Boston Scientific, Biosense Webster, and Abbott; and has received grants from Boston Scientific, Medtronic, Abbott, and Biotronik. Dr. Vemulapalli receives grants for clinical research from Abbott Vascular, Boston Scientific, National Institutes of Health, Patient Centered Outcomes Research Institute, Food and Drug Administration (NEST), American College of Cardiology, Society of Thoracic Surgeons; and serves as a consultant to Janssen, Boston Scientific, Heartflow, Baylabs (Caption Health), and the American College of Physicians. Dr. Granger has received funding support and/or honoraria from The Medicines Company, Pfizer, and AstraZeneca; and has been a consultant for Pfizer and AstraZeneca. Dr. Peterson has received grant support from the American College of Cardiology, the American Heart Association, and Janssen; and has served as a consultant for Bayer, Boehringer Ingelheim, Merck, Valeant, Sanofi, AstraZeneca, Janssen, Regeneron, and Genentech. Dr. Piccini has received grants for clinical research from Abbott, the American Heart Association, the Association for the Advancement of Medical Instrumentation, Bayer, Boston Scientific, and Philips; and has served as a consultant to Abbott, Allergan, ARCA Biopharma, Biotronik, Boston Scientific, LivaNova, Medtronic, Milestone, Myokardia, Sanofi, Philips, and Up-to-Date. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.